about
Treating Negative Symptoms in Schizophrenia: an UpdatePathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric DisordersFrom Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismPostmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewThe Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?omicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data.IL1R2, CCR2, and CXCR4 May Form Heteroreceptor Complexes with NMDAR and D2R: Relevance for Schizophrenia.Transcriptome sequencing study implicates immune-related genes differentially expressed in schizophrenia: new data and a meta-analysis.Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study.IFNGR2 genetic polymorphism associated with sex-specific paranoid schizophrenia risk.A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human StudiesPsychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study.Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?Neuroteratology and Animal Modeling of Brain Disorders.Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence.Investigating the neuroimmunogenic architecture of schizophrenia.Immunoadolescence: Neuroimmune development and adolescent behavior.The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia.Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.Personalized medicine in psychiatry.Biological hypotheses and biomarkers of bipolar disorder.Epigenetic Research in Neuropsychiatric Disorders: the "Tissue Issue".Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Potential drug targets and treatment of schizophrenia.Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders.Differential antibody responses to gliadin-derived indigestible peptides in patients with schizophreniaDNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia Subjects.Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defectsAssociation of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.Immunoinflammatory Therapies in Psychiatry: Current Evidence Base.Expression of schizophrenia biomarkers in extraocular muscles from patients with strabismus: an explanation for the link between exotropia and schizophrenia?Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry.Hydrolysis by catalytic IgGs of microRNA specific for patients with schizophrenia.Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.Decreased Expression of IFNG-AS1, IFNG and IL-1B Inflammatory Genes in Medicated Schizophrenia and Bipolar Patients.Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression.Maternal immune activation in neurodevelopmental disorders.Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.Prenatal Immune Challenge in Mice Leads to Partly Sex-Dependent Behavioral, Microglial, and Molecular Abnormalities Associated with Schizophrenia.
P2860
Q26744805-95AFAF78-18EC-4E52-BA20-6999CE1917CDQ26745690-C66F320A-16AF-4702-8265-1F502A16D34FQ28067617-3B82F6FF-D9E2-4A46-A1C4-83A405C8F097Q28077391-44EBF666-1088-4EB1-AB2C-15F9F2DD0750Q28077460-88DF96FB-0C69-41A9-BE3E-9F17E723D766Q30827406-6AC71161-9DD4-4FE6-9722-ABF349A86F50Q33364911-6A3B132D-306D-4C57-B60C-C6E5C61180F1Q33635637-423BAF6A-51F8-4757-9514-A617E82D01FEQ36113742-2DA41D19-FDB2-4892-9080-FFC1A9BAE70EQ36114055-FF0C812A-0A92-45CD-9FBE-E602980F1ED6Q36740391-FC06EF5B-63BB-4645-A447-7C88D7232CC3Q37414075-0CEF8113-ECCB-40FF-8F29-DB6E50DF28CDQ37721268-EA6076F7-4045-41C9-A2EC-47834CAD8298Q38726690-11D9BF35-7EA2-4498-B268-04BA43AE0F2EQ38739624-C9241C67-2DE0-4538-AF44-33271B966452Q38796321-AA31ACC4-CD99-42D8-9318-15488E0FBF68Q38853365-275BABA2-F034-44D8-B66A-1961C87CCA51Q38877141-4EFC3C1F-FC17-42BD-847E-377EF73633EEQ38919287-C43527A5-CAC7-4A55-908C-E5B242576CE1Q38937776-187688A1-5D54-44E5-AFE0-176041DF3414Q38995726-3D4D9733-8CAD-4549-8767-44A2278EA688Q39091292-7977C1CE-6A8B-4B73-8969-B42B772E70B6Q39094833-244172C1-8F20-42AD-AE6F-348C16ED9380Q39130393-6C67F651-12FA-4241-8694-01F074605524Q39206300-8B8AE328-D64E-4E38-A0D0-953F189796C5Q39458323-9CE4BB94-9AE0-4A89-A220-7D30208C298DQ41173224-0254557F-1315-4530-8843-C019AD5F14E5Q42251222-9F62DA77-6824-4F9C-8628-D5152E33400BQ42619183-87BF218E-C14A-46A3-9214-95AF854FFC90Q46686779-1B9F8107-6F4C-4CE5-9B29-720FCA6131E7Q47137430-C5B537F2-9BB1-493F-9F11-B229265E07ADQ47147925-54E9F4B6-74C2-4C3E-9320-46489B1EC6A5Q47331971-2884B0CD-02EA-463F-A891-8C392E513B2CQ47554999-FB41A481-1AC1-4713-8740-69586AAC024DQ47571860-9179D6B5-95CD-4BA1-B86D-AFE6D801D4C9Q47651631-BE195D49-248E-474E-949D-CEA3BAFF3818Q47935886-20833F69-2C21-4EA4-9FC2-2CBD635373DFQ48144016-4F53C210-30B5-47C9-AB99-19761E7C895AQ48621584-240995B9-CB70-4083-BBC0-423AA20B0067Q50152745-C552D02C-B976-4B51-B8A3-A53030337BC9
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The role of inflammation in schizophrenia
@ast
The role of inflammation in schizophrenia
@en
The role of inflammation in schizophrenia
@nl
type
label
The role of inflammation in schizophrenia
@ast
The role of inflammation in schizophrenia
@en
The role of inflammation in schizophrenia
@nl
prefLabel
The role of inflammation in schizophrenia
@ast
The role of inflammation in schizophrenia
@en
The role of inflammation in schizophrenia
@nl
P2093
P2860
P3181
P356
P1476
The role of inflammation in schizophrenia
@en
P2093
Bianka Leitner
Elif Weidinger
Markus J Schwarz
Norbert Müller
P2860
P3181
P356
10.3389/FNINS.2015.00372
P407
P577
2015-01-01T00:00:00Z